42nd Annual ETA Meeting

1123 Budapest, Hungary
Symposium

42nd Annual ETA Meeting

European Thyroid Association (ETA)

Date:
Sep 07, 2019, 08:00 - Sep 10, 2019, 15:00
Scientific Organization:
European Thyroid Association - ETA
Summary:
The 42nd Annual Meeting of the European Thyroid Association (ETA) will be held in Budapest, Hungary. The ETA meeting claims to be one of the world´s most prestigious thyroid scientific conventions in an environment which is also world renowned for its rich scientific and cultural heritage. The scientific program will feature fundamental and clinical thyroid research, framed by varying social activities like the gala dinner.
Credits: applied for

physicians / medical specialists

max. no. of participants: unlimited
Min fee: 160,00 EUR

Mind:
before June 30

ETA Ordinary and ETA Senior: € 160,00
ETA Corresponding: € 260,00
ATA, LATS, AOTA, JTA members *: € 260,00
Non-Member: € 500,00


from July 1

ETA Ordinary and ETA Senior: € 185,00
ETA Corresponding: € 300,00
ATA, LATS, AOTA, JTA members *: € 300,00
Non-Member: € 550,00

residents in training

max. no. of participants: unlimited
Min fee: 60,00 EUR

Mind:
before June 30

ETA Junior <35y: € 60,00

from July 1

ETA Junior <35y: € 80,00



students

max. no. of participants: unlimited
Min fee: 125,00 EUR

Mind:
before June 30

Students/Res. Fellows <30y: € 125,00


from July 1

Students/Res. Fellows <30y: € 160,00

other

max. no. of participants: unlimited
Min fee: k.A.

Comment:
This event takes place annually and offers the opportunity for continued medical education for physicians / medical specialists, residents in training, students and other.
The organizer has applied for CME-accreditation by the European Accreditation Council for Continuing Medical Education (EACCME).
Eventnumber: 31240
CME-certification: applied for
Min fee:
 
Places available: unlimited
Language: Englisch
 
Published program by the organizer:

 

   
Saturday, 7. Sep 2019  
   
08:00 - 13:00 ETA Clinical Update
13:45 - 14:00 Opening Ceremony
14:00 - 16:00 Oral Session 1: Topic Highlights
17:00 - 18:00 ETA Industry-sponsored Satellite Symposium 1
18:15 - 18:35 Historical Vignette: Commemorating 70 years of antithyroid drugs
18:35 - 19:20 ETJ Lecture
   
   
   
Sunday, 8. Sep 2019  
   
07:00 - 08:00 ETA Industry-sponsored Satellite Symposium 2
08:00 - 09:30 Symposium 1: US guided interventional therapy of nodular thyroid disease

  • ETA Questionnaire survey on current practice (Enrico Papini, Italy)
  • ETA Guidelines on US interventional therapy of nodular disease (Herve Monpeyssen, France)
  • Therapy of microcarcinoma – active surveillance vs. Treatment (debate) (Eleonora Molinaro, Italy)
   
10:00 - 11:30 Oral Session 2 Clinical (Room Patria)
Oral Session 3 Basic (Room Bartok II)
   
12:30 - 13:30 ETA Industry-sponsored Satellite Symposium 3
   
13:30 - 14:15  Meet the Expert 1 - Thyroid hormone analogues: An update (Paul Ladenson, USA)
Meet the Expert 2 - Trace Elements and Thyroid function (Michael Zimmermann, Switzerland)
Meet the Expert 3 - Thyroid cancer after nuclear accidents: to screen or not to screen for? (Furio Pacini, Italy)
Meet the Expert 4 - Adverse effects of immune checkpoint inhibitors (Maria Alevizaki, Greece)
   
14:15 - 15:45 Oral Session 4 Clinical
Oral Session 5 Basic
   
16:00 - 17:00 ETA Industry-sponsored Satellite Symposium 4
   
17:00 - 18:30 Symposium 3: New Insights in Graves’ orbitopathy

  • Current understanding in the aetiopathogenesis of Graves’ orbitopathy (Terry Smith, USA)
  • Imaging techniques in the diagnosis and consequences for Graves’ orbitopathy management (Endre Nagy, Hungary)
  • New medical treatment modalities in moderate to severe Graves’ orbitopathy (George Kahaly, Germany)
   
17:00 - 18:30 Symposium 4: Thyroid cancer translational Symposium

  • TERT aberrations in Thyroid Cancer (Catharina Larsson, Sweden)
  • DNA methylation as marker of prognosis in differentiated thyroid cancer (Mireira Jorda, Spain)
  • Novel molecular markers of Differentiated Thyroid Cancer progression (Christopher McCabe, United Kingdom)
  • miRNA as prognostic factors in the follow-up of Medullary Thyroid Cancer (Maria Grazia Borrello, Italy)
   
18:35 - 18:50 Lissitzky Award
   
   
   
Monday, 9. Sep 2019  
   
07:00 - 08:00 ETA Industry-sponsored Satellite Symposium 5
   
08:00 - 09:30 Symposium 5: Joint Symposium ETA/EANM: Impact of the new classification (Room Patria)

  • Impact on pathological classification (or for the Pathologist) (Guido Fadda, Italy)
  • Impact on clinical classification (or for the Clinician) (Romana Teodora Netea-Maier)
  • Impact on indication for treatment (or for Nuclear Medicine) (Frederik Verburg, Germany)
   
08:00 - 09:30 Symposium 6: Novel aspects of Thyroid hormone signaling (Room Bartok II)

  • TR ligand binding
  • Physiological relevance of canonical and non-canonical Thyroid hormone signaling (Lars Christian Moeller, Germany)
  • Clinical disorders of Thyroid hormone signaling (TR alpha and beta) (Carla Moran, United Kingdom)
   
10:00 - 11:30 Oral Session 6 Clinical (Room Patria)
Oral Session 7 Basic (Room Bartok II)
   
12:30 - 13:30 ETA Industry-sponsored Satellite Symposium 6
   
13:30 - 14:15 Meet the Expert 5 - Guidelines on Graves’ disease (Simon Pearce, United Kingdom)
Meet the Expert 6 - Conception, birth and development of a clinical trial on advanced thyroid cancer (Manisha H. Shah, USA)
Meet the Expert 7 - Common genetic variants: why of interest? (Marco Medici, Netherlands)
Meet the Expert 8 - Endocrine Disruptors (Barbara Demeneix)
   
14:30 - 16:00 Oral Session 8 Clinical (Room Patria)
Oral Session 9 Basic (Room Bartok II)
   
16:10 - 17:10 Short Call Abstracts
   
17:10 - 17:50 Pinchera Prize Lecture
   
18:00 - 19:00 General Assembly
   
   
   
Tuesday, 10. Sep 2019  
   
08:00 - 08:30 Research Grant 2017 - Winner Presentations
   
08:30 - 10:30  Oral Session 10: Young Investigators / Clinical + Translational (Room Patria)
Oral Session 11: Young Investigators / Basic (Room Bartok II)
   
11:00 - 13:00 Oral Session 12 Clinical (Room Patria)
Oral Session 13 Basic (Room Bartok II)
   
13:10 - 14:40 Symposium 7: Subclinical Hypothyroidism: What has been missed (Room Patria)

Tissue signal of subclinical hypothyroidism other than serum TSH (Leonidas Duntas, Greece)
Adherence to therapy and the economic burden of subclinical hypothyroidism (Peter Taylor, UK)
Avoiding overtreatment and undertreatment by an individually tailored dose or alternative thyroxine preparations
(Marco Centanni, Italy)
   
13:10 - 14:40 Symposium 8: Central Control of Thyroid hormone action (Room Bartok II)

Tanycytes control the hormonal output of the hypothalamic-pituitary-thyroid axis (Markus Schwaninger, Germany)
Role of endocannabinoids and glutamate in the regulation of TRH release in the median eminence by tanycytes
(Csaba Fekete, Hungary)
Type 2 deiodinase polymorphism (Antonio Bianco, USA)
   
14:40 - 15:00 Prize Ceremony and Closure
   
Venue:
BCC - Budapest Congress Center
Address:
1-3, Jagelló út
1123 Budapest, Hungary
Scientific Organization:
European Thyroid Association - ETA
Event-Organizer:

European Thyroid Association - ETA
ETA Standing Office
EndoScience - Endokrinologie Service GmbH
Sandra Crutchley
Hopfengartenweg 19
DE - 90518 Altdorf
Tel.: +49 (0)6136 762 197
Fax: +49 (0)6136 761 953

 
Mind:

 

Bitte wenden Sie sich für weitere Informationen direkt an den Veranstalter.